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Case presentation
A 35-year-old man was referred to the Southwestern Medical Center
because of a history of severe renal stone disease for one year. During that
time he passed 21 stones spontaneously and had required left nephro-
lithotomy one month prior to his initial visit. Analysis of the stone
disclosed the presence of calcium oxalate. His dietary history revealed a
moderately low intake of fluids and a limited intake of nuts, but a heavy
intake of beef and poultry. He had no history of intestinal disease,
diarrhea, gout, primary hyperparathyroidism, peptic ulcer disease, or
hypertension. He denied a family history of gout, urolithiasis, or primary
hyperparathyroidism.
Evaluation disclosed a serum total calcium of 9.8 mg/dl; serum inor-
ganic phosphorus, 3.0 mg/dl; and PTH, 250 pg/mI (normal, 100—400
pg/mi). The serum creatinine was 1.2 mg/dl; BUN, 11 mg/dl; and endog-
enous creatinine clearance, 115 mi/mm. The serum sodium concentration
was 141 mEq/liter; potassium, 4.2 mEq/liter; chloride, 102 mEq/liter; total
C02, 27 mEqlliter; total protein, 7.2 g/dl; albumin, 4.7 g/dl; alkaline
phósphatase, 94 lU/liter; and serum uric acid concentration, 7.1 mg/dl
(normal, 2.3—8.0 mg/dl).
The 24-hour urine volume was low, ranging from 760—1020 mi/day. The
24-hour urinary pH was between 5.8 and 6.2, and the fasting urinary pH
was 5.4. Urinary calcium on a random diet, as well as on a calcium- and
sodium-restricted diet, was within normal limits, ranging from 110—176
mg/day (normal, <200 mg/day). A fasting urinary calcium was 0.05 mg/100
ml glomerular filtrate (normal, <0.11 mg/100 ml glomerular filtrate).
Following ingestion of 1 g of calcium glubionate, his urinary calcium was
0.18 mg/mg creatinine (normal, <0.20 mg/mg creatinine). Urinary uric
acid was normal at 588 mg/day (normal, <600 mg/day). Urinary citrate
was low at 114—206 mg/day (normal, >320 mg/day). Urinary sulfate was
highly elevated at 46—54 mmol/day (normal, <25 mmol/day), consistent
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with a high intake of meat and poultry. A KUB disclosed the presence of
3 stones in his right kidney.
Potassium citrate, 20 mEq four times per day orally, was prescribed, and
his fluid intake.was increased to achieve a minimum urine output of 2
liters/day. His urinary volume on followup examination ranged between
2000—2400 mI/day. His urinary sulfate excretion has decreased, ranging
between 28—32 mmol/day, due to a reduction in his beef intake. His
urinary citrateexcretion has risen to very high levels, persistently ranging
between 915—1088 mg/day. He has tolerated this regimen and has not
developed any new stones over the past 12 years.
Discussion
DR. ROBERT J. ALPERN (Chief Division of Nephrologv; Ruth W.
and Milton P. Levy, Sr., Chair in Molecular Nephrology; and
Professor of Internal Medicine, The University of Texas Southwestern
Medical Center, Dallas, Texas): This patient has one key risk factor
that predisposes to recurrent kidney stones: a low urinary citrate
level. The low urinary citrate level was due to excessive dietary
intake of protein with a consequent increase in metabolic acid
production. In this Nephrology Forum, I will review the body's
response to excess acid ingestion or to excess metabolic acid
production. In general, while most of the response is beneficial in
preventing extreme levels of metabolic acidosis, a number of the
compensatory mechanisms contribute to the generation and pro-
gression of kidney stones, bone disease, renal disease, and a
catabolic state.
Renal responses to acid
The ingestion of excessive dietary acid or, equivalently, a diet
that causes excess metabolic acid production results initially in an
acute metabolic acidosis. This derangement, however, normally is
followed by chronic adaptations in renal mechanisms of acid
excretion that return blood pH and serum bicarbonate concen-
trations toward the normal range. In the steady state, acid-base
parameters may be normal, in spite of significant increases in
dietary acid ingestion.
Proximal tubule hydrogen ion secretion. A major function of the
proximal tubule in metabolic acidosis is reabsorption of the
majority of filtered bicarbonate. This process results in low distal
delivery of bicarbonate. Because the proximal tubule is a pump-
leak system with a significant leak rate, net H/HCO3 transport
is determined by the relative rates of transcellular H secretion
and paracellular bicarbonate backleak. Thus, any maneuver that
increases the rate of transcellular H secretion is expected to
lower end-proximal tubular bicarbonate concentration and distal
delivery of bicarbonate {1, 2].
The capacity of the proximal tubule to secrete hydrogen ions
has been examined using in-vivo microperfusion, in which rates of
bicarbonate absorption can be measured in the absence of
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Fig. 1. Effect of 24 hrs of/ow [HC031 (acid) pre-incubation on Na/H
ant/porter activity in MCT and OKP cells. Following pre-incubation in
control (LII) or acid (iII) media for 24 hours, Na/H ' antiporter activity
was assayed as the rate of Na-dependent cell pH recovery following an
acid load (pHi/dt). Bars and error bars represent mean SE. (Reprinted
with permission from Ref. 14.)
changes in luminal composition. Acute decreases in blood pH and
bicarbonate concentration increase transcellular H secretion [3].
But chronic acid feeding, which produces a much smaller change
in blood pH and bicarbonate concentration, produces a larger
increase in the rate of H secretion [4]. This chronic increase in
transcellular H secretion is due to chronic adaptations in the
apical membrane Na/H antiporter and the basolateral mem-
brane Na/HCO37CO3 symporter, the two major H/HCO3
transporters of the proximal tubule [5, 61. Kinetically, both these
adaptations involve an increase in the Vmax of the transporter.
This adaptive process is not limited to the kidney; in-vivo meta-
bolic acidosis also increases lymphocyte Na !H antiporter activ-
ity[7].
In these studies, acidosis was induced in whole animals. The
accompanying proximal tubular adaptations may be signaled
directly by changes in intracellular or extracellular pH, or indi-
rectly by acidosis-induced changes in hormone levels, renal nerve
activity, or hemodynamics. To determine whether changes in pH
directly induce adaptations in proximal tubular transporters, we
examined the effect of acidifying media on NatiH antiporter
activity in primary cultures of rabbit proximal tubule cells. Expo-
sure to acid media (pH = 0.3 pH units) for 48 hours caused an
increase in Na/H antiporter activity that persisted when cells
were studied in the absence of the acid environment [81. This
increase in Na1H antiporter activity occurred in response to
increases in pCO2 or decreases in HCO3 concentration, and was
dependent on protein synthesis.
Proximal tubules express at least two Na/H antiporter iso-
forms. The hasolateral membrane Na/H antiporter is similar to
that expressed ubiquitously in nonpolar cells, and is likely en-
coded by the NHE-1 gene [9]. This isoform is inhibited by low
concentrations of amiloride and arniloride analogues such as
ethylisopropyl amiloride (EIPA) [10]. This antiporter is unlikely
to mediate transepithelial H secretion, and most likely contrib-
utes to so-called housekeeping functions such as cell pH defense,
growth, and signaling. A second Na/H antiporter, present on
Fig. 2. RNA blot showing Na/H ant/porter (JVHE-1) and /3 actin tran-
script levels in MCT cells after 24 hours of pre-incubation in control or
low-[HCO3J media. (Reprinted with permission from Ref. 14.)
the apical membrane, mediates transepithelial hydrogen secretion
and sodium absorption. This Na/H antiporter requires higher
concentrations of amiloride and EIPA for inhibition [10], and
likely is encoded by the NHE-3 isoform, which is expressed mainly
in kidney and intestine [11—13]. To study the effect of acid
incubation on these distinct isoforms, we identified renal cell lines
that selectively expressed either El PA-sensitive or EIPA-resistant
Na/H antiporter activity. The MCT cell is an SV4O-trans-
formed mouse proximal tubule cell line that possesses an EIPA-
sensitive Na7H antiporter. The OKP cell is a clonal cell line
derived from opossum kidney, which expresses many characteris-
tics of the proximal tubule, and expresses an EIPA-resistant
Na/H antiporter.
Incubation of MCT cells and OKP cells in acid media for 24
hours caused an increase in Na/H antiporter activity, which
again persisted after the cells were removed from acid (Fig. 1)
[14]. These results suggested that both isoforms are regulated by
acidosis. The MCT cells express NilE-i mRNA, consistent with
EIPA-sensitive Na!H antiporter activity. Incubation of MCT
cells in acid media for 24 hours caused a threefold increase in
NHE-1 mRNA abundance (Fig. 2) [14]. Similarly, chronic meta-
bolic acidosis in vivo raised the renal cortical NHE-1 mRNA level
[14, 15]. We recently cloned an OKP cell Na/H4 antiporter that,
based on homology, appears to be NHE-3 [16]. Again, this finding
is consistent with the presence of an EIPA-resistant Na/H
antiporter in these cells. Incubation of OKP cells in acid media
caused a two- to threefold increase in NHE-3 mRNA (unpub-
lished observation, Amemiya M, Yamaji Y, Cano A, Moe OW,
Alpern RJ). Thus, in-vitro incubation of proximal tubule cells in
acid media increases the activities of amiloride-sensitive and
amiloride-resistant Na /H antiporters, which correspond to
increases in NHE-1 and NHE-3 mRNA abundance, respectively.
Collecting duct H'!HCO transport. The cortical collecting
duct is capable of net H secretion or net HCO3 secretion [17].
These transport functions are mediated by two cell types: type-A
intercalated cells secrete H, and type-B intercalated cells secrete
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HC03 [1]. The net effect of these "opposing" transport pro-
cesses is determined by systemic acid-base status and dietary acid
or alkali content. Thus, if cortical collecting ducts are dissected
from animals fed an acid diet, they secrete acid, whereas if
dissected from animals fed an alkaline diet, they secrete base [17].
Interconversion between these two states occurs in the absence of
cell death or cell proliferation [18]. The exact mechanism respon-
sible for interconversion is not clear, but it appears to involve
changes in the relative activities of type-A and type-B intercalated
cells [19]. In-vitro incubation of dissected cortical collecting ducts
in acid media elicits cellular remodeling of type-B intercalated
cells, similar to that which occurs during chronic acidosis in vivo
[20]. Madias and colleagues have demonstrated that chronic
respiratory acidosis also produces a two- to threefold increase in
renal Cl/HC01 exchanger (band 3) mRNA abundance [21].
This exchanger mediates base efflux in type-A intercalated cells
[1].
Ammoniagenesis. Increases in tubular net hydrogen secretion
require the availability of increased luminal buffer. The buffer
most responsible for acidosis-induced increases in net acid excre-
tion is ammonia. Ammonia synthesis in the renal proximal tubule
derives from glutamine, and involves a series of sequential steps
including glutamine transport into the cell across the apical and
basolateral membranes, transport into mitochondria, and metab-
olism of glutamine to glutamate by glutaminase, and then to
alpha-ketoglutarate by glutamate dehydrogenase [1]. For contin-
ued ammoniagenesis, the alpha-ketoglutarate must be metabo-
lized further in the tricarboxylic acid cycle, where the resulting
carbon atoms typically contribute to gluconeogenesis.
Chronic metabolic acidosis causes a number of adaptations that
lead to increased rates of ammoniagenesis. These adaptations
include increased activities of glutaminase, glutamate dehydroge-
nase, and phosphoenolpyruvate carboxykinase (PEPCK), the
rate-limiting enzyme in gluconeogenesis. Changes in these three
enzyme activities are associated with increases in their respective
mRNA abundance [22—241. Exposure of cultured LLC-PK1-F+
cells to acid media increases the activities and mRNA abundances
of all three enzymes; these increases demonstrate a direct effect of
extracellular fluid acidification [22, 25]. In addition, in that the
apical membrane Na/H antiporter mediates ammonium trans-
port from cell to lumen in the proximal tubule, chronic adapta-
tions in this transporter will contribute to increased availability of
luminal ammonia for buffering [26—281.
Trade-offs in the response to acidosis
In general, all the kidney's responses to acidosis that I have
referred to increase net acid excretion, returning blood p1-I toward
the normal range. In addition to these adaptations, others also
help return blood pH to normal values but have additional effects
that are detrimental. Thus, in order to maintain acid-base balance,
the body accepts certain trade-offs.
Proximal tubule citrate absorption. Citrate is the most prevalent
of the organic anions in the urine. Organic anions represent
potential base because their metabolism generates HCO3. Ci-
trate has three carboxyl groups, and consequently metabolism of
one citrate molecule generates 3 HC03 ions. Retention of
citrate and other organic anions by the kidney, therefore, is
beneficial during metabolic acidosis, while increased citrate excre-
tion is beneficial during metabolic alkalosis. Nevertheless, by
reducing citrate excretion, the kidney's response to acidosis
carries a clinically important price, because citrate complexes
calcium, making urinary citrate one of the most important inhib-
itors of calcium crystallization. Pak's group has shown that
hypocitraturia is one of the most common risk factors for calcium
oxalate stone formation [29]. 1 have no doubt that, in the patient
we are discussing, hypocitraturia was responsible for his predis-
position to stones.
Citrate is freely filtered by the renal glomerulus and is reab-
sorbed (up to 99% of the filtered load) in the proximal tubule [30,
31]. Proximal tubular reabsorption serves as the sole regulator of
urinary citrate excretion. Citrate, absorbed from the lumen into
the proximal tubule cell via an apical membrane Na4 /citrate
co-transporter, then is metabolized in the proximal tubule cell.
The precise pathways involved in citrate metabolism are not
totally understood. Citrate potentially could enter mitochondria
on a tricarboxylate transporter that functions as an exchanger.
Inside mitochondria, citrate would be metabolized—possibly to
malate—which could then exit the mitochondria on the tricar-
boxylate transporter (in exchange for citrate) and eventually feed
into gluconeogenesis.
In the liver, where the mitochondrial tricarboxylate transporter
has been characterized most completely, the transporter likely
serves as a citrate/malate exchanger, with citrate exiting mitochon-
dna [32]. Citrate is then metabolized in the cytoplasm by ATP
citrate lyase, which provides the major cytoplasmic source for
acetyl CoA used in fatty acid synthesis. This enzyme catalyzes the
reaction
ATP + citrate + CoA —p ADP + phosphate + acetyl CoA
+ oxaloacetate
Feeding animals a diet low in fat causes a 100-fold induction of
the mRNA for ATP citrate lyase in liver [33]. Little attention has
been paid as to whether ATP citrate lyase is a route for metabo-
lism of reabsorbed citrate in the renal proximal tubule. Whereas
mRNA expression for this enzyme is lower in kidney than in liver,
the kidney does express it [33]. High rates of apical membrane
citrate transport conceivably could lead to cytoplasmic concentra-
tions sufficiently high to drive citrate into mitochondria in the
renal proximal tubule, in contrast to its exit from mitochondria in
the liver.
Two mechanisms have been defined by which acidosis can
acutely increase proximal tubule citrate absorption. First, luminal
pH affects the valence of luminal citrate. The apical membrane
Nat/citrate co-transporter carries citrate only in the monoproto-
nated 2- valence. Given the 3 pKs for citrate of 3.1, 4.8, and 6.4,
and the fact that proximal tubular luminal pH varies from 6.5 to
7.3, the more acidic the luminal fluid, the higher the fraction of
citrate that occurs in the monoprotonated form at the expense of
the 3- valence form. Wright et al found that citrate uptake in
brush-border membrane vesicles was regulated by extravesicular
pH, and that this effect was totally accounted for by the effect of
pH on the concentration of monoprotonated citrate [34]. A
second mechanism that has been defined for acute regulation of
citrate absorption is stimulation of transport into mitochondria by
decreased cell pH. Simpson, Hager, and Angielski have per-
formed extensive studies demonstrating that decreases in extra-
mitochondrial bicarbonate concentration increase rates of unidi-
rectional citrate uptake [35, 36].
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The relative importance of these two mechanisms became clear
when Brennan and Hamm examined the relative effects of luminal
and peritubular acidification on citrate absorption in the isolated
perfused proximal tubule [37]. Note that decreases in peritubular
pH have a more significant effect on cell pH than do decreases in
luminal pH [38]. Brennan and coworkers found that while de-
creases in luminal pH markedly increased citrate absorption,
decreases in peritubular pH had only a small effect, which could
be explained fully by secondary changes in luminal pH [37]. These
investigators argued from these findings that acute changes in cell
pH were unlikely to be a major regulator of citrate metabolism
and transport and that the major site of acute regulation likely is
the apical membrane transporter. On the other hand, a number of
studies have found that acute acidosis decreases renal cortical
tissue citrate levels; this observation suggests that the major
mechanism of regulation is altered metabolism [30].
With chronic acidosis and chronic acid feeding, changes in
blood pH are small, changes in luminal pH are likely to be small,
and changes in cell pH should be extremely small. Of note, the
patient being discussed today had a serum total CO2 concentra-
tion of 27 mmollliter in spite of chronically increased net acid
production. Thus, chronic changes in citrate transport and metab-
olism likely require very sensitive adaptations in these mecha-
nisms. In support of this concept, chronic acidosis leads to an
adaptive increase in the activity of the apical membrane Na47
citrate co-transporter [39]. This increase is likely triggered by a
decrease in cell pH in that potassium deficiency, which causes
intracellular acidosis and extracellular alkalosis, produces the
same adaptive stimulation of the Na/citrate co-transporter [401.
We are currently investigating whether similar adaptations occur
in the mitochondrial transporter or in ATP citrate lyase.
Calcium and bone metabolism. If renal mechanisms are not able
to maintain acid-base balance, the body uses a second defense
mechanism, namely, bone resorption. Bone provides a large
reservoir of bicarbonate and carbonate, and mobilization of this
reservoir ameliorates the acidosis. Acutely, metabolic acidosis
causes HC03 release from bone, which is associated with release
of sodium and potassium [41]. Exposure of cultured mouse
calvariae to acid for 3 hours causes hydrogen uptake and calcium
release; 16—21 nEq of protons are buffered for each nEq of
calcium released [42]. The effect of pH on calcium mobilization in
this preparation is similar in live and dead bone. The acute effect
thus is due to physicochemical processes and is independent of
cell function [43].
By contrast, acid buffering by bone in chronic metabolic acidosis
is accompanied by CaCO3 release and is associated with cell-
mediated bone remodeling [41]. In cultured neonatal mouse
calvariae, decreases in pH and HCO3 concentration cause
calcium mobilization after 48 hours, only if cells are alive [44].
This cell-mediated calcium efflux results from inhibited osteoblas-
tic calcium deposition and stimulated osteoclastic calcium mobi-
lization [45, 46]. Intracellular acidification of osteoclasts decreases
cell calcium and is associated with adhesion to bone [47].
Metabolic acidosis also directly inhibits renal tubular calcium
reabsorption and causes hypercalciuria. Because this effect is seen
in hypokalemic distal RTA, but not in proximal RTA, the effect
appears to occur through regulation of distal calcium absorption
by luminal pH. Indeed, lysine infusion into dogs, which causes
metabolic acidosis but increased distal HC03 delivery, stimu-
lates tubular calcium reabsorption [48]. Recent studies in cultured
distal nephron cells (connecting segment plus collecting duct)
found a profound inhibitory effect of decreased luminal pH on
calcium uptake and transepithelial transport [49]. Changes in cell
pH had no effect. Thus, metabolic acidosis causes bone resorption
and hypercalciuria by three mechanisms: (1) an acute direct
physicochemical effect of extracellular fluid pH on mineral
HCO3; (2) a chronic effect of acidosis on osteoblastic activity
(inhibition) and on osteoclastic activity (stimulation), resulting in
bone remodeling; and (3) a direct effect of decreased luminal pH,
which inhibits calcium reabsorption in the distal nephron.
Protein catabolism. As I mentioned, an important response to
chronic metabolic acidosis is an increase in renal ammoniagenesis.
Most synthesized ammonia is derived from glutamine generated
extrarenally. Thus, one can predict that acidosis should increase
net protein breakdown. This prediction was confirmed by May et
al [50]. Chronic metabolic acidosis induced by feeding rats acid
caused a 43% increase in urinary nitrogen excretion. Muscle
isolated from these animals demonstrated increased rates of
protein degradation, with no change in the rate of protein
synthesis. In cultured BC3H1 myocytes, decreases in extracellular
pH increase protein degradation and decrease protein synthesis
[51]. Chronic metabolic acidosis in intact animals also increases
amino acid oxidation and increases the activity of hepatic and
muscle branched-chain ketoacid dehydrogenase activity [52, 53].
By comparison, renal branched-chain ketoacid dehydrogenase
activity decreases in acidosis. All these changes lead to increased
net protein degradation and the generation of a catabolic state in
chronic acidosis. While these changes may be beneficial for
maintenance of plasma glutamine levels and secondarily en-
hanced ammoniagenesis, this adaptation clearly is detrimental
over the long term. Indeed, substantial evidence indicates that
chronic metabolic acidosis contributes importantly to the cata-
bolic state of uremia [54, 55].
Progression of renal disease. Acidosis causes renal hypertrophy
and hyperplasia [56]. Hypertrophy has been implicated in the
progression of renal disease. In addition, hypokalemia, which is
associated with intracellular acidification, is associated with renal
cyst formation [57]. In Han:SPRD rats, a model of polycystic
kidney disease, NH4CI increased, and KHCO3 ameliorated, renal
cyst formation [58]. Similarly, in rat models of hypokalemic
nephropathy and remnant kidney, NaHCO3 administration de-
creased renal injury [59, 60].
Acid-induced increases in renal growth occur by a number of
mechanisms. First, chronic acidosis is associated with increases in
renal cortical ammonia levels, which cause hypertrophy of proxi-
mal tubule cells in vitro [61]. This effect appears to be related to
inhibition of protein degradation, possibly because of effects on
lysosomal pH. Second, acidosis causes resistance to the growth-
suppressive effects of TGFJ3 in proximal tubule cells [62]. Last,
acidosis increases c-src activity, protein tyrosine phosphorylation,
and activation of immediate early genes, all of which are associ-
ated with growth and which could contribute to acidosis-induced
renal growth (see later). In addition, the increase in ammonia
levels induced by acidosis can activate complement and in this
manner also contribute to progression of renal disease [59, 60].
f-low do cells sense acid?
The adaptations I have discussed involve changes in cell
function that occur in response to acidosis. Although it is tempting
to view acidosis as a process that modulates cell function by
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Fig. 3. Effect of acid incubation orphorbol ester on AP-1 activity; autoradiograph of a thin-layer chromatography plate. MCT cellswere stably transfected
with a reporter plasmid p6xTRE/IFNCAT and exposed to control media (c), acid medium (a), or phorbol ester (p) for the times indicated. Lower dots
indicate unacetylated chloramphenicol; upper dots indicate acetylated chloramphenicol. Chloramphenicol aeetyltransferase activity is indicated by the
percentage of chioramphenicol appearing in the acetylated form. (Reprinted with permission from Ref. 65.)
titrating amino acids on many different proteins, it is worth noting
that chronic metabolic acidosis is rarely associated with changes in
blood or cell pH that are greater than 0.05—0.10 pH units. As a
general rule, the function of most proteins remains unaffected by
pH changes of this magnitude. Thus the existence of specific
pH-sensitive proteins designed to sense small pH changes is a
more likely explanation. Such proteins could function in two ways.
First, a single protein could contain the pH sensor and the
pH-regulated effector mechanism; an example of this is the
Na17H antiporter, which can sense cell pH and regulate
Na/H exchange activity accordingly [63j. Second, in a cell in
which many functions are regulated by pH, pH-sensitive proteins
might trigger a signaling cascade similar to that activated by
hormone receptors; this cascade eventually might result in both
acute and chronic regulation of numerous processes. Such a
scenario likely would exist in the renal proximal tubule, where pH
changes result in many physiologic alterations, such as changes in
the activities of the H/HCO3 transporters and the ammonia-
genic enzymes, and changes in citrate absorption and metabolism.
In addition, other forms of acid-induced regulation—such as
osteoclast and osteoblast function, regulation of type-A and
type-B intercalated cells, muscle metabolism, and renal growth—
also might be regulated by similar signaling mechanisms.
We have studied acid-activated signaling pathways in cultured
proximal tubule cells. We found that chronic activation of protein
kinase C caused a persistent increase in the activity of an
EIPA-sensitive Na/l-r antiporter in primary cultures of rabbit
proximal tubule cells [641. This effect depended on transcription
and translation, and was associated with increases in NHE-1
mRNA abundance. Thus, the response to chronic protein kinase
C activation was similar to the response to chronic metabolic
acidosis. In addition, we found that the effect of acid on the
activity of the EIPA-sensitive Na/H antiporter of MCT cells
was prevented by inhibition of protein kinase C [65].
Because these studies suggested a role for protein kinase C in
acid-induced activation of NT-fE-i, we next examined the effect of
acid on the activity of a transcription factor that frequently
mediates protein kinase C regulation of gene expression. Many
genes with transcription rates that are regulated by protein kinase
C have in their 5' flanking region a concensus nucleotide se-
quence, TGA(C/G)TCA, referred to as a TRE, or IPA response
lement. When AP-1, a transcription factor, binds to the TRE, the
rate of transcription of the gene increases. The promoters of the
human and rabbit NHE-1 gene have been cloned, and both
contain a TRE [66, 67]. To examine whether acid increases AP-i
activity, MCT cells were stably transfected with a gene containing
6 copies of a TRE upstream of a minimal interferon promoter and
the reporter gene ehloramphenieol acetyltransferase (CAT) [65].
Figure 3 shows results from incubation of MCI' cells in control
media (c), acid media (a), or control media with phorbol ester (a
protein kinase C activator) (p). Both acid incubation and phorbol
ester increased CAT activity; thus both increase AP-1 activity.
AP-1 is a heterodimer of members of the fos and jun immediate
early gene transcription factor families. As Figure 4 illustrates,
acid incubation increased mRNA abundance for c-fos and c-jun in
MCT cells [65]. In addition, acid incubation increased mRNA
abundance of junB and egr-1, two other immediate early genes
[68]. Similarly, acute metabolic acidosis induced in vivo by NH4C1
gavage caused similar increases in mRNA abundance of these
immediate early genes [68].
These immediate early genes typically are activated by growth
factors and by other hormones, but they also can be increased
somewhat nonspecifically by any maneuver that inhibits protein
synthesis. Because acidosis inhibits protein synthesis in some cells,
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Fig. 4. Effect of acid incubation on c-fos (A) and c-jun (B) mRNA abundance. At time 0 medium was changed to either control medium (c) or low pH
(a). GAPDH was used as a loading control. (Reprinted with permission from Ref. 65.)
we next examined whether this mechanism was responsible for
acid activation of these immediate early genes. Our approach was
to inhibit protein synthesis maximally with cycloheximide. In this
setting, acid incubation is unlikely to affect protein synthesis
further. We found that inhibition of protein synthesis increased
mRNA abundance of these immediate early genes, but that acid
incubation increased abundance even further [68]. In fact, the
increase obtained with acid incubation was greater and more
prolonged in the presence of cycloheximide. This so-called super-
induction is commonly seen with growth factor activation of
immediate early genes. Nuclear run-on studies demonstrated that
acid-induced increases in immediate early gene mRNA abun-
dance were secondary to increases in transcription.
Thus, incubation of proximal tubule cells in acid media leads to
increases in immediate early gene mRNA that are related to
increases in transcription rate and that are superinduced by
inhibition of protein synthesis. These characteristics are similar to
immediate early gene activation by growth factors. The signaling
pathways of interest, therefore, are likely to be similar to those
induced by growth factors. In general, growth factors activate
c-jun
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GAPDH
15mm 30mm
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immediate early genes either through protein kinase C/cell calci-
um-related pathways or through tyrosine kinase pathways. Both
these pathways converge into a signaling pathway that includes,
sequentially, ras, raf, MEK, and MAP kinase. We therefore next
examined whether the observed activation of immediate early
genes was occurring through protein kinase C, a calcium-activated
pathway, or a tyrosine kinase pathway. Inhibition of protein
kinase C or prevention of increases in cell calcium had no effect
on acid induction of immediate early genes [68]. Indeed, acid
incubation did not raise cell calcium in MCT cells. However,
incubation of MCT cells with herbimycin A, an inhibitor of
tyrosine kinase pathways, prevented acid activation of the imme-
diate early genes [68].
Additional studies also support a role for a tyrosine kinase
pathway. Acidification of proximal cells in vitro increased tyrosine
phosphorylation of proteins of approximately 120 and 60—70 kDa
[69]. Membrane fractionation studies showed that the tyrosine-
phosphoiylated proteins were cytoplasmic. No evidence was
found for phosphorylation of a plasma membrane protein, as
would be expected with activation of growth factor receptors. We
therefore next examined the src family of non-receptor tyrosine
kinases. Using a peptide substrate specific for this family of
tyrosine kinase, we demonstrated a twofold increase in kinase
activity for this peptide substrate in extracts from acid-treated
cells [69]. Similarly, renal cortical extracts from acid-fed animals
showed a twofold increase in kinase activity for this peptide
substrate. More recently, we have utilized immunoprecipitating
anti c-src antibodies to demonstrate that acid incubation activates
c-src activity [70].
These studies suggest that acidosis activates protein kinase C,
immediate early genes, and tyrosine kinase pathways, possibly
through c-src activation. The major question that remains is, how
does acidosis activate protein kinase C and c-src? Current evi-
dence suggests that c-src is inhibited by phosphorylation of
tyrosine 527. Csk, a tyrosine kinase, phosphorylates c-src at this
position, thus maintaining it in an inactive form. Most maneuvers
that activate c-src dephosphorylate this tyrosine. Thus, acidosis
might inhibit csk, stimulate a tyrosine phosphatase, or regulate the
activity of a more upstream kinase or phosphatase.
In cultured MCT cells, decreases in extracellular and intracel-
lular pH had no effect on cellular calcium [69]. In other cell types,
however, acidosis increases cellular calcium. In cultured human
fibroblasts, decreasing extracellular pH increased cellular calcium.
The increase, due to calcium release from intracellular stores, was
associated with increased inositol trisphosphate (1P3), and was
half-maximal at an extracellular pH of 6.5 [71]. In mitochondrial-
rich cells of turtle urinary bladder, cultured inner medullary
collecting duct (IMCD) cells, and perfused outer medullary
collecting duct cells, intracellular acidification raised cellular
calcium [72—74]. In the IMCD, the increase in calcium was due to
release from intracellular stores and was associated with IP3
production; in the turtle bladder, the increase in cellular calcium
resulted from an influx of extracellular calcium.
Clinical implications
Metabolic acidosis clearly can exert diverse effects on the body,
many of which contribute to the return of pH toward normal
values, but some of which are detrimental. Preventing metabolic
acidosis therefore seems prudent. This is generally accomplished
by treating the cause of the acidosis, or by administering NaHCO3
or sodium citrate. Although physicians frequently utilize the
serum bicarbonate level as an index of whether alkali treatment is
adequate, this strategy is clearly not adequate in all circumstances.
Large increases in net acid intake or production, such as those
that occurred in the patient discussed here, can be accompanied
by normal serum bicarbonate and pH. However, the resulting
increase in net acid production still elicits compensatory mecha-
nisms, which contributed to this patient's stone disease. Failure to
treat metabolic acidosis adequately can result in kidney stones,
bone disease, and increased renal growth. The last effect can
contribute to an increased rate of progression of renal disease and
to exacerbation of renal cystic disease. Further, acidosis can
contribute to the catabolic state associated with chronic renal
insufficiency. The most sensitive clinical indicator of whether the
body is responding to an increased acid load is urinary citrate
excretion. Measurements of urinary citrate should be adopted as
standard practice when considering whether a patient has an
increased acid load that is triggering both beneficial and detri-
mental defense mechanisms.
Questions and answers
DR. NIcoLAos E. MADIAS (Chief Division of Nephrology, New
England Medical Center, Boston, Massachusetts): You stated that
metabolic acidosis activates several immediate early genes typi-
cally activated by growth factors and that it causes renal hyper-
trophy and hyperplasia. But how does renal growth develop, given
that metabolic acidosis also stimulates protein degradation and, at
least in some cells, that it inhibits protein synthesis?
DR. ALPERN: The answer to this question is likely related to the
cell specificity of the response. We have not found any effect of
acidifying media on cell growth in cultured renal cells. Conversely,
acidification of media inhibits growth in fibroblasts. As I discussed
earlier, incubation of renal cells in acid media leads to increases in
immediate early gene expression. In NIH 3T3 cells, a fibroblast
cell line, we found a similar reponse, but the mechanism is
different [68]. In NIH 3T3 cells, the effect is likely mediated by
inhibition of protein synthesis, in that prior inhibition of protein
synthesis with cycloheximide prevents the ability of acid to
increase immediate early gene mRNA expression. As I noted
earlier, in cultured renal cells, inhibition of protein synthesis
causes superinduction of immediate early gene mRNAs. Thus it
appears that acidosis is growth suppressive and catabolic in
extrarenal cells, whereas it is growth stimulatory in renal cells.
DR. MADIAs: Several of these immediate early genes also are
activated in models of acute renal failure and are presumably
involved in tissue repair. Is the accompanying metabolic acidosis
important for the activation of these genes in this setting?
DR. ALPERN: Immediate early genes are activated in many
conditions. It is not clear where the specificity lies. It is possible
that immediate early genes are activated in conditions in which
many other genes must be activated. In that acid increases
immediate early gene expression, it might be beneficial where
tissue repair is required.
DR. MMIA5: What is the current understanding of the role that
activation of the NHE-1 isoform plays in growth and prolifera-
tion?
DR. ALPERN: The role of NHE-1 activation in growth and
proliferation is very similar to that of immediate early genes. We
know that NHE-1 activation occurs in most forms of growth and
proliferation, but the role of this activation remains unclear. That
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cells can grow in the absence of NHE-1 implies that the activation
of NHE-1 is not required in cell growth. Nevertheless, it seems
likely that NHE-1 does play a role in this setting.
DR. RICHARD LAFAYETrE (Division of Nephrology, New England
Medical Center): I am fascinated by your theory of the trade-off of
metabolic acidosis leading to renal growth. One wonders whether
acidosis could lead to progression of renal disease by initiating
renal growth and causing glomerular hypertrophy. Is anything
known regarding acidosis leading to glomerular hypertrophy?
DR. ALPERN: Only one study has examined the growth effects of
acidosis. Lotspeich found that chronic metabolic acidosis caused
increases in renal protein content and DNA, with the increase in
protein content out of proportion to that of DNA [56]. These
studies thus demonstrate hypertrophy and hyperplasia. No at-
tempt was made in these studies to distinguish glomerular from
tubular growth. However, given the relative masses of glomeruli
and tubules, an effect on renal protein and DNA generally implies
an effect on tubules. Nevertheless, there may also have been an
effect on glomeruli.
DR. LAFAYETFE: Despite the renal growth with acidosis, you
mentioned that TGFI3, thought to be a potent effector of inter-
stitial and glomerular scarring, seems to be inhibited. In that case,
the renal acidification might be protective to the kidney in
preventing chronic injury. Is any more known about this?
DR. ALPERN: Your conclusion is similar to ours. We performed
a series of studies attempting to show an effect of media acidifi-
cation on growth of cultured renal cells. In general, these studies
were negative. Because of TGFI3's pronounced antiproliferative
effect, we examined whether media acidification would modify this
effect. The results demonstrated that TGFI3 inhibited prolifera-
tion and that acidosis inhibited the effect of TGFI3. Thus, in the
presence of TGFJ3, acidifying media increased the rate of prolif-
eration. To study the signaling mechanisms that might be respon-
sible for this effect, we examined phosphorylation of the retino-
blastoma protein (RB). The TGF inhibited EGF-induced
phosphorylation of RB [62]. This effect of TGFI3 also was
inhibited by media acidification. In that RB is known to play a key
role in the antiproliferative effect of TGFI3, the interaction
between media acidification and TGFI3 is likely due to regulation
of RB. However, no data currently indicate whether RB mediates
the effects of TGF/3 on matrix synthesis. Thus, it is not clear
whether acidosis' ability to inhibit the TGFI3 effect also applies to
regulation of matrix synthesis. Harold Franch and Patricia Preisig
in our group are currently examining this question.
DR. ANDREW KING (Division of Nephrology, New England Med-
ical Center): Several neurohumoral factors such as angiotensin II,
norepinephrine, and endothelin are well known as modulators of
sodium-proton antiport. Are these factors related to c-src? Do
these factors alter the kidney's ability to handle acid?
DR. ALPERN: That is a very interesting question. It has recently
been shown that endothelin activates c-src in mesangial cells [751.
This also might be true in proximal tubule cells, but it has not been
examined. Whether these hormones play any role in mediating
the renal response to acid is not known.
DR. ANDREW LEVEY (Division of Nephroloy, New England
Medical Center): I'd like to ask you to return to this patient's
problem. Your hypothesis seems to be that, even in the absence of
demonstrable metabolic acidosis, the increased acid load has
caused some of these trade-offs to occur in the kidney. My first
question is: Are the available methods sensitive enough to dem-
onstrate either positive acid balance or reduced intracellular pH
in humans? Second, would provision of sodium bicarbonate or
potassium bicarbonate rather than citrate correct the hypocitruria
and the stone disease just as well as provision of the citrate itself?
DR. ALPERN: Increases in net acid production secondary to
ingestion of dietary acid lead to increases in renal net acid
excretion in the presence of minimal degrees of metabolic acido-
sis. As you know, frequently there is no change in the serum
bicarbonate that we can detect. This might be related to our
inability to measure the small changes in serum bicarbonate and
pH that occur. Perhaps the adaptive mechanisms are able to sense
these small changes.
With regard to your second question, bicarbonate and citrate
are equally effective in correcting the hypocitruria. Administration
of citrate does not directly increase citrate excretion. Rather,
citrate is metabolized by the liver to bicarbonate, and it is the
alkaline load that increases urinary citrate excretion. Physicians
frequently use citrate rather than bicarbonate because it is better
tolerated by patients. In the stomach, bicarbonate reacts with
secreted hydrogen ion to form C02, and can lead to a feeling of
bloating. In patients with renal insufficiency, citrate can increase
aluminum absorption and likely should be avoided. In this setting,
sodium bicarbonate remains the best treatment.
DR. LEVEY: So in patients with hypocitruria and renal stones,
bicarbonate administration produces equally successful results.
DR. ALPERN: We have performed exactly the study you have
described. In collaboration with Khashayar Sakhaee and Charlie
Pak, we found that administration of bicarbonate or citrate causes
similar effects on urinary citrate excretion [761.
DR. LEVEY: What are the other causes of hypocitruria besides
exaggerated dietary protein intake?
DR. ALPERN: In essence, any condition that causes a chronic
acidosis or an increased acid load will cause hypocitruria. This
association has been best described with hypokalemic distal renal
tubular acidosis and with chronic diarrheal states [77, 78]. You
also can see this with chronic potassium deficiency secondary to
intracellular acidosis. Pak and associates showed that you can see
it in patients who exercise a lot and in patients who ingest
excessive amounts of meat [79J. Pak also has found some patients
in whom there is no obvious cause for hypocitruria [80]. The
possibility of a genetic predisposition is currently being addressed.
DR. JULIE NEURINGER (Division of Nephrology, New England
Medical Center): You said there's also a significant amount of src
in bone. Is there any evidence that intracellular acidification
affects bone cells the way it affects kidney cells? Might this be
important in regulating the effect of chronic acidosis on bone?
DR. ALPERN: That is a good point. It turns out that src is very
important in bone. In mice in which the c-src gene has been
knocked out, the major phenotypic abnormality is osteopetrosis,
which is due to a defect in osteoclast function [811. Thus, src plays
an important role in bone resorption. Although not tested, it
remains possible that acid activation of c-src is responsible for the
effects of acidosis on bone.
DR. MADIAS: Is the stimulation of the sodium/citrate co-
transporter in the proximal tubule specific in metabolic acidosis?
DR. ALPERN: Metabolic acidosis has a number of effects on
apical membrane transport mechanisms in the proximal tubule. It
stimulates the Na/citrate cotransporter, stimulates the apical
membrane Na/H* antiporter, and inhibits the Na/phosphate
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cotransporter. Both Na/glucose and Na/amino acid transporters
are unaffected.
DR. MAmAs: What is the nature of the apical Ca2 influx
mechanism in the distal nephron that is inhibited by acid luminal
pH? Is it known where this mechanism actually resides?
DR. ALPERN: This mechanism has not been defined, In all
likelihood, it is a calcium channel, but this remains to be estab-
lished. Its location is likely in the apical membrane of the
connecting tubule or the distal convoluted tubule.
DR. MADIAS: Do you have any insights into the mechanism of
the differential effects of acid on NHE-1 expression in renal
epithelial cells versus fibroblasts? In your cell culture experiments,
how long does the "memory effect" of pre-existing exposure to
acid persist in sustaining activation of the NHE-1 and NHE-3
isoforms?
DR. ALPERN: The differential effects of acid in proximal tubule
cells and in fibroblasts are very interesting. Acid incubation
increases NHE-1 activity and mRNA in renal cells, although it
decreases them in fibroblasts. These opposite results are not due
to different isoforms; in both cases we are dealing with the NHE-1
isoform. It is possible that this differential response is related to
the differential response of immediate early genes that I discussed
earlier.
With regard to your second question, in all our experiments,
cells are incubated in control media for one hour following the
control or acid incubation. We have not performed time courses
examining how long it takes the effect to go away. Those would be
very interesting experiments.
DR. MADIAs: Do we know whether chronic respiratory acidosis
results in adaptation of the sodium/citrate co-transporter or the
enzymes involved in ammoniagenesis?
DR. ALPERN: I am not aware of any studies that have examined
the effect of chronic respiratory acidosis on the adaptation of the
Na/citrate co-transporter. The key probably will be whether there
is a persistent decrease in cell pH. As you know, chronic respira-
tory acidosis does not produce the increases in ammonia synthesis
that occur with chronic metabolic acidosis. With regard to the
effects of chronic respiratory acidosis on apical membrane
Na/H antiporter activity, results have been conflicting, with two
groups showing an effect and two groups not showing an effect
[82—851. In cell culture experiments, we showed that chronic
increases in pCO2 elicit the same adaptation in Na/H anti-
porter activity that a decrease in bicarbonate concentration elicits
[8]. The complicated response to respiratory acidosis in vivo might
be related to confounding hemodynamic effects.
DR. MiuIAs: To what extent are your studies using potassium
depletion to regulate the Na/citrate co-transporter complicated
because of the potential for generating metabolic alkalosis? What
method did you use to produce the potassium depletion?
DR. ALPERN: We produced potassium deficiency by placing the
animals on a zero-potassium diet [40]. We can minimize the
degree of metabolic alkalosis by using a high-sodium diet. Any
metabolic alkalosis that occurs tends to ameliorate the effect of
potassium deficiency on the Na/citrate co-transporter.
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